Your browser doesn't support javascript.
loading
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study.
Mair, Maximilian J; Berger, Julia M; Mitterer, Manfred; Gansterer, Margaretha; Bathke, Arne C; Trutschnig, Wolfgang; Berghoff, Anna S; Perkmann, Thomas; Haslacher, Helmuth; Lamm, Wolfgang W; Raderer, Markus; Tobudic, Selma; Fuereder, Thorsten; Buratti, Thomas; Fong, Dominic; Preusser, Matthias.
Affiliation
  • Mair MJ; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: https://twitter.com/@MJ_Mair.
  • Berger JM; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Mitterer M; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, 39012 Meran, Merano, Italy.
  • Gansterer M; Faculty of Management and Economics, University of Klagenfurt, 9020 Klagenfurt, Austria.
  • Bathke AC; Department of Artificial Intelligence and Human Interfaces and Intelligent Data Analytics Lab Salzburg, University of Salzburg, 5020 Salzburg, Austria.
  • Trutschnig W; Department of Artificial Intelligence and Human Interfaces and Intelligent Data Analytics Lab Salzburg, University of Salzburg, 5020 Salzburg, Austria.
  • Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
  • Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
  • Lamm WW; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Raderer M; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Tobudic S; Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Fuereder T; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
  • Buratti T; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, 39012 Meran, Merano, Italy.
  • Fong D; Hemato-Oncological Day Hospital Unit, Franz Tappeiner Hospital, 39012 Meran, Merano, Italy.
  • Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Electronic address: matthias.preusser@meduniwien.ac.at.
Eur J Cancer ; 165: 184-194, 2022 04.
Article in En | MEDLINE | ID: mdl-35248840
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article